Recurrence of cervical cancer in mice after selective estrogen receptor modulator therapy

American Journal of Pathology

Volumn 184, Issue 2, 2014, Pages 530-540

  Spurgeon, Megan E ^a   Chung, Sang Hyuk ^b   Lambert, Paul F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; MINICHROMOSOME MAINTENANCE PROTEIN 7; RALOXIFENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CANCER RECURRENCE; CARCINOGENESIS; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG CLEARANCE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM; WART VIRUS;

ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EPITHELIUM; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENITALIA, FEMALE; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84892164262     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.10.013     Document Type: Article

References (22)

1. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer, and N. Munoz Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
2. F.X. Bosch, A.N. Burchell, M. Schiffman, A.R. Giuliano, S. de Sanjose, L. Bruni, G. Tortolero-Luna, S.K. Kjaer, and N. Munoz Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia Vaccine 26 Suppl 10 2008 K1 K16
3. WHO/IARC: WHO/IARC World Cancer Report, 2008. International Agency for Research on Cancer, Lyon, France. Available online at http://www.iarc.fr/en/ publications/pdfs-online/wcr/2008/index.php
4. M. Schiffman, P.E. Castle, J. Jeronimo, A.C. Rodriguez, and S. Wacholder Human papillomavirus and cervical cancer Lancet 370 2007 890 907
5. N. Munoz, S. Franceschi, C. Bosetti, V. Moreno, R. Herrero, J.S. Smith, K.V. Shah, C.J. Meijer, and F.X. Bosch Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study Lancet 359 2002 1093 1101
6. V. Moreno, F.X. Bosch, N. Munoz, C.J. Meijer, K.V. Shah, J.M. Walboomers, R. Herrero, and S. Franceschi Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study Lancet 359 2002 1085 1092
7. P. Luhn, J. Walker, M. Schiffman, R.E. Zuna, S.T. Dunn, M.A. Gold, K. Smith, C. Mathews, R.A. Allen, R. Zhang, S. Wang, and N. Wentzensen The role of co-factors in the progression from human papillomavirus infection to cervical cancer Gynecol Oncol 128 2013 265 270
8. P. Appleby, V. Beral, A. Berrington de Gonzalez, D. Colin, S. Franceschi, A. Goodhill, J. Green, J. Peto, M. Plummer, and S. Sweetland Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies Lancet 370 2007 1609 1621
9. S.H. Chung, S. Franceschi, and P.F. Lambert Estrogen and ERalpha: culprits in cervical cancer? Trends Endocrinol Metab 21 2010 504 511
10. E.L. Salazar, E. Mercado, I. Sojo, and M. Salcedo Relationship between estradiol 16 alpha-hydroxylation and human papillomavirus infection in cervical cell transformation Gynecol Endocrinol 15 2001 335 340
11. S. Rinaldi, M. Plummer, C. Biessy, X. Castellsague, K. Overvad, and S. Kruger Kjaer et al. Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study Cancer Epidemiol Biomarkers Prev 20 2011 2532 2540
12. J.M. Arbeit, P.M. Howley, and D. Hanahan Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice Proc Natl Acad Sci U S A 93 1996 2930 2935
13. D.A. Elson, R.R. Riley, A. Lacey, G. Thordarson, F.J. Talamantes, and J.M. Arbeit Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis Cancer Res 60 2000 1267 1275
14. R.R. Riley, S. Duensing, T. Brake, K. Munger, P.F. Lambert, and J.M. Arbeit Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis Cancer Res 63 2003 4862 4871
15. S.F. Jabbar, S. Park, J. Schweizer, M. Berard-Bergery, H.C. Pitot, D. Lee, and P.F. Lambert Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein Cancer Res 72 2012 4008 4016
16. T. Brake, and P.F. Lambert Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model Proc Natl Acad Sci U S A 102 2005 2490 2495
17. S.H. Chung, and P.F. Lambert Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists Proc Natl Acad Sci U S A 106 2009 19467 19472
18. S.H. Chung, M.K. Shin, K.S. Korach, and P.F. Lambert Requirement for stromal estrogen receptor alpha in cervical neoplasia Horm Cancer 4 2013 50 59
19. S.H. Chung, K. Wiedmeyer, A. Shai, K.S. Korach, and P.F. Lambert Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer Cancer Res 68 2008 9928 9934
20. R. Herber, A. Liem, H. Pitot, and P.F. Lambert Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene J Virol 70 1996 1873 1881
21. S. Song, A. Liem, J.A. Miller, and P.F. Lambert Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis Virology 267 2000 141 150
22. T. Brake, J.P. Connor, D.G. Petereit, and P.F. Lambert Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer Cancer Res 63 2003 8173 8180